Trial Profile
Teneligliptin improves glycemic control with the reduction of postprandial insulin requirement in Japanese diabetic patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Feb 2016
Price :
$35
*
At a glance
- Drugs Teneligliptin (Primary)
- Indications Diabetic complications
- Focus Therapeutic Use
- 02 Feb 2016 New trial record